Saroja Pharma Industries India Ltd
₹ 43.0
1.78%
29 Apr
- close price
About
Saroja Pharma Industries India is engaged in amongst the leading traders, exporter and suppliers of Specialty Chemicals. The offered range is widely praised for its superior effectiveness, shelf life and perfect composition
[
edit about
]
[
add key points
]
- Market Cap ₹ 17.3 Cr.
- Current Price ₹ 43.0
- High / Low ₹ 82.9 / 35.0
- Stock P/E 16.3
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 22.1 %
- ROE 23.2 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| 36.66 | 55.63 | 50.19 | |
| 35.36 | 53.53 | 47.47 | |
| Operating Profit | 1.30 | 2.10 | 2.72 |
| OPM % | 3.55% | 3.77% | 5.42% |
| 0.09 | 0.32 | 0.16 | |
| Interest | 0.33 | 0.80 | 1.32 |
| Depreciation | 0.02 | 0.05 | 0.07 |
| Profit before tax | 1.04 | 1.57 | 1.49 |
| Tax % | 28.85% | 28.03% | 28.86% |
| 0.73 | 1.14 | 1.06 | |
| EPS in Rs | 730.00 | 50.49 | 3.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 23% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | 0.01 | 0.23 | 2.94 |
| Reserves | 0.93 | 3.80 | 2.15 |
| 3.02 | 6.14 | 10.18 | |
| 4.26 | 5.34 | 6.07 | |
| Total Liabilities | 8.22 | 15.51 | 21.34 |
| 0.09 | 0.34 | 2.22 | |
| CWIP | 0.00 | 0.00 | 1.79 |
| Investments | 0.00 | 0.04 | 0.14 |
| 8.13 | 15.13 | 17.19 | |
| Total Assets | 8.22 | 15.51 | 21.34 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| -1.05 | -3.67 | 2.19 | |
| -0.05 | -0.34 | -4.82 | |
| 1.03 | 4.27 | 2.73 | |
| Net Cash Flow | -0.07 | 0.26 | 0.10 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Debtor Days | 71.88 | 91.73 | 80.80 |
| Inventory Days | 7.23 | 3.41 | 31.18 |
| Days Payable | 45.43 | 38.52 | 47.22 |
| Cash Conversion Cycle | 33.68 | 56.62 | 64.76 |
| Working Capital Days | 38.13 | 62.20 | 70.83 |
| ROCE % | 33.55% | 22.09% |
Documents
Announcements
Annual reports
No data available.